FindTrial
Sign In

Study on improving prognosis of patients with hypoxemia after lung cancer surgery by nasal high flow oxygen therapy

Study on improving prognosis of patients with hypoxemia after lung cancer surgery by nasal high flow oxygen therapy

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400081335
Enrollment
Unknown
Registered
2024-02-28
Start date
2024-02-28
Completion date
Unknown
Last updated
2024-03-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hypoxemia

Interventions

Non-invasive ventilator unit:Use a non-invasive ventilator
High nasal flow group:Use high flow through the nose

Sponsors

Beijing Chest Hospital Affiliated to Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
40 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1). Age 40-80 years old, 2). Oxygenation index less than 300, 3). Resection of lung lobe where VATS tumor is located. 4) Obtain patient cooperation, relevant informed consent and ethical consent.

Exclusion criteria

Exclusion criteria: 1). Disturbance of consciousness; 2) Patients with tracheotomy; 3). Severe nausea and vomiting; 4). Hemoptysis or active bleeding; 5) Hemodynamic instability; 6). Mouth and nose deformity.

Design outcomes

Primary

MeasureTime frame
Ventilator-related collateral injury;—

Secondary

MeasureTime frame
Vital sign;Blood gas analysis;Inflammatory index;ICU stay;ICU hospitalization cost;GCQ Comfort Scale;—

Countries

China

Contacts

Public ContactLiu Ying

Beijing Chest Hospital Affiliated to Capital Medical University

852226369@qq.com+86 182 3150 6015

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026